Sigma-Aldrich Corporation (NASDAQ: SIAL) today announced it has entered into an exclusive agreement with the Wellcome Trust Sanger Institute to manufacture and distribute the Sanger Institute's ...
FRANKFURT, GERMANY, December 11, 2024 /EINPresswire.com/ -- Vivlion GmbH, a leader in CRISPR-based screening technologies, today announced the launch of its new ...
Researchers are applying CRISPR-Cas9 as a stoichiometric binding tool to improve NGS library normalization. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results